TCIM
NEOS

TIAA CREF Investment Management’s Neos Therapeutics, Inc NEOS Stock Holding History

TIAA CREF Investment Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$245K Buy
93,684
+25,715
+38% +$60.3K ﹤0.01% 2844
2018
Q4 		$112K Buy
67,969
+16,950
+33% +$47.6K ﹤0.01% 2948
2018
Q3 		$247K Sell
51,019
-2,283
-4% -$12.9K ﹤0.01% 2935
2018
Q2 		$333K Sell
53,302
-1,739
-3% -$13K ﹤0.01% 2919
2018
Q1 		$457K Sell
55,041
-35,951
-40% -$343K ﹤0.01% 2781
2017
Q4 		$928K Buy
90,992
+31,836
+54% +$305K ﹤0.01% 2506
2017
Q3 		$541K Buy
59,156
+12,303
+26% +$93.5K ﹤0.01% 2792
2017
Q2 		$342K Buy
46,853
+2,168
+5% +$16.4K ﹤0.01% 3006
2017
Q1 		$322K Hold
44,685
– – ﹤0.01% 2911
2016
Q4 		$261K Sell
44,685
-489
-1% -$3.31K ﹤0.01% 3003
2016
Q3 		$297 Hold
45,174
– – ﹤0.01% 3000
2016
Q2 		$419K Buy
45,174
+29,151
+182% +$278K ﹤0.01% 2940
2016
Q1 		$173K Hold
16,023
– – ﹤0.01% 3001
2015
Q4 		$229K Hold
16,023
– – ﹤0.01% 3052
2015
Q3 		$337K Buy
+16,023
New +$353K ﹤0.01% 2978

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIAA CREF Investment Management's NEOS Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Neos Therapeutics, Inc (NEOS) stake by 38% in Q1 2019, buying an estimated $60.3K and bringing the position to 93,684 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #2844.

TIAA CREF Investment Management first reported a position in NEOS in Q3 2015 and has held it in 15 quarters since. The position peaked at $928K in Q4 2017. 63 funds tracked by Wall St. Rank hold NEOS as of Q1 2019.

  • TIAA CREF Investment Management held 93,684 shares of Neos Therapeutics, Inc worth $245K as of Q1 2019.
  • TIAA CREF Investment Management bought 25,715 Neos Therapeutics, Inc shares in Q1 2019, an estimated $60.3K.
  • Neos Therapeutics, Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2844 holding.
  • TIAA CREF Investment Management first reported a position in Neos Therapeutics, Inc in Q3 2015 and has held it in 15 quarters since.
  • TIAA CREF Investment Management's Neos Therapeutics, Inc position peaked at $928K in Q4 2017.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.